# Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Two Reference Products

> **NCT02627625** · PHASE1 · COMPLETED · sponsor: **Solventum US LLC** · enrollment: 31 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tiotropium

## Key facts

- **NCT ID:** NCT02627625
- **Lead sponsor:** Solventum US LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-03
- **Final completion:** 2016-06
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2024-12-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02627625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02627625, "Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Two Reference Products". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02627625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*